Clinical trial
Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel…
NCT00441883 · Bausch & Lomb Incorporated, Industry · Completed
Key facts
| NCT number | NCT00441883 |
|---|---|
| Title | Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma |
| Official title | A Phase 2, 28 Day Parallel-Group, Double-Masked, Dose-Finding Study Comparing the Safety and Efficacy of PF-03187207 to Latanoprost |
| Lead sponsor | Bausch & Lomb Incorporated, Industry |
| Collaborators | NicOx Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Primary Open Angle Glaucoma, Ocular Hypertension, Pigmentary Glaucoma, Pseudoexfoliative Glaucoma |
| Intervention type | Drug |
| Interventions | PF-03187207 and Latanoprost Vehicle, Latanoprost 0.005% and PF-03187207 Vehicle |
| Enrollment | 176 |
| Start date | Mar 1, 2007 |
| Primary completion | Feb 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | Mar 1, 2007 |
| Last update posted | Sep 14, 2020 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: